
ViewRay VRAY
Quarterly report 2023-Q1
added 05-11-2023
ViewRay Operating Expenses 2011-2026 | VRAY
Annual Operating Expenses ViewRay
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 117 M | 104 M | 102 M | 115 M | 81.7 M | 54.5 M | 40.5 M | 37.3 M | 24.4 K | 22.1 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 117 M | 24.4 K | 67.4 M |
Quarterly Operating Expenses ViewRay
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 28.2 M | - | - | - | 27.6 M | - | 25.2 M | 24.8 M | 25 M | - | 23.9 M | 24.5 M | 27.9 M | - | 32.3 M | 29.5 M | 25 M | - | 24.5 M | 18.3 M | 16.9 M | - | 13.6 M | 12.6 M | 11.1 M | - | 10.1 M | 10.2 M | 11 M | - | 8.31 M | 10.7 M | 7.54 M | - | 6.77 M | 1.82 K | 4.16 K | 471 | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 32.3 M | 471 | 16.9 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BioSig Technologies
BSGM
|
12.9 M | - | 37.08 % | $ 85.7 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | ||
|
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | ||
|
Xtant Medical Holdings
XTNT
|
80.3 M | $ 0.55 | -2.31 % | $ 73.5 M | ||
|
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | ||
|
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | ||
|
Zimmer Biomet Holdings
ZBH
|
4.46 B | $ 88.57 | -0.65 % | $ 18 B | ||
|
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | ||
|
Alphatec Holdings
ATEC
|
614 M | $ 10.93 | -5.12 % | $ 1.64 B | ||
|
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | ||
|
Accuray Incorporated
ARAY
|
139 M | $ 0.4 | 4.21 % | $ 41.1 M | ||
|
Insulet Corporation
PODD
|
531 M | $ 208.22 | -4.53 % | $ 14.6 B | ||
|
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | ||
|
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | ||
|
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | ||
|
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | ||
|
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | ||
|
CONMED Corporation
CNMD
|
648 M | $ 34.58 | -5.62 % | $ 1.07 B | ||
|
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | ||
|
NanoVibronix
NAOV
|
5.09 M | - | - | $ 1.08 M | ||
|
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M | ||
|
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | ||
|
Cytosorbents Corporation
CTSO
|
41.9 M | $ 0.59 | -1.18 % | $ 32.1 M | ||
|
Aethlon Medical
AEMD
|
9.34 M | $ 2.15 | -5.29 % | $ 3.36 M | ||
|
Edwards Lifesciences Corporation
EW
|
1.99 B | $ 79.34 | -3.36 % | $ 46.4 B | ||
|
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | ||
|
AdaptHealth Corp.
AHCO
|
59.6 M | $ 11.2 | -1.84 % | $ 1.51 B | ||
|
OrthoPediatrics Corp.
KIDS
|
212 M | $ 15.52 | -5.08 % | $ 364 M | ||
|
Invacare Corporation
IVC
|
260 M | - | - | $ 24.7 M | ||
|
Ra Medical Systems
RMED
|
26.8 M | - | 10.0 % | $ 610 K | ||
|
Myomo
MYO
|
41.3 M | $ 0.7 | 2.32 % | $ 29.3 M | ||
|
Penumbra
PEN
|
753 M | $ 335.1 | -0.39 % | $ 13 B | ||
|
Inspire Medical Systems
INSP
|
240 M | $ 50.13 | -0.63 % | $ 1.47 B | ||
|
Pulmonx Corporation
LUNG
|
121 M | $ 1.17 | -5.65 % | $ 47.6 M | ||
|
Cutera
CUTR
|
198 M | - | -10.19 % | $ 1.99 M | ||
|
Eargo
EAR
|
126 M | - | - | $ 10.2 M | ||
|
NuVasive
NUVA
|
777 M | - | - | $ 2.07 B | ||
|
Nevro Corp.
NVRO
|
396 M | - | - | $ 217 M | ||
|
Surgalign Holdings
SRGA
|
120 M | - | -32.98 % | $ 1.68 M | ||
|
STRATA Skin Sciences
SSKN
|
18.2 M | - | - | $ 6.6 M | ||
|
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | ||
|
AVITA Medical
RCEL
|
101 M | $ 3.82 | -1.04 % | $ 106 M | ||
|
AxoGen
AXGN
|
121 M | $ 31.28 | -3.01 % | $ 1.44 B |